Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 385 entries
View as:

Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06253065 Org: User:
Start: 01/12/24 End: 12/31/25 Due: 12/31/26

Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05964595 Org: User:
Start: 07/01/23 End: 12/31/25 Due: 12/31/26

MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05626127 Org: User:
Start: 11/20/22 End: 12/01/24 Due: 12/01/25

Small Sample，Unicentric，Randomized, Controlled Clinical Study of Coenzyme I for Injection in the Treatment of Sudden Sensorineural Hearing Loss

Phase: N/A Priority: Normal
NCT ID: NCT05849519 Org: User:
Start: 02/16/22 End: 02/16/24 Due: 02/16/25

Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05466786 Org: User:
Start: 07/15/22 End: 05/31/27 Due: 05/31/28

Long-Term Outcomes of Robot-Assisted Radical Cystectomy: A Real-World Study

Phase: N/A Priority: Normal
NCT ID: NCT05856825 Org: User:
Start: 05/01/23 End: 12/31/23 Due: 12/31/24

Study of Opioid Immunosuppressive Effects

Phase: N/A Priority: Normal
NCT ID: NCT01881802 Org: User:
Start: 03/31/13 End: - Due: -

Longitudinal Study on the QoL of Pediatric Patients After HSCT and Its Influencing Factors

Phase: N/A Priority: Normal
NCT ID: NCT06026839 Org: User:
Start: 10/30/23 End: 12/31/24 Due: 12/31/25

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06148402 Org: User:
Start: 11/08/23 End: 06/30/26 Due: 06/30/27

Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）

Phase: N/A Priority: Normal
NCT ID: NCT04027543 Org: User:
Start: 11/14/18 End: 12/01/19 Due: 12/01/20

Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)

Phase: N/A Priority: Normal
NCT ID: NCT05693987 Org: User:
Start: 11/01/22 End: 04/30/23 Due: 04/30/24

A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC

Phase: N/A Priority: Normal
NCT ID: NCT04803539 Org: User:
Start: 04/01/21 End: 09/01/33 Due: 09/01/34

Cavity Shaving in Breast Conserving Surgery for Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02648802 Org: User:
Start: 01/31/16 End: 08/20/19 Due: 08/20/20

Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01)

Phase: N/A Priority: Normal
NCT ID: NCT04003558 Org: User:
Start: 05/28/19 End: 01/01/25 Due: 01/01/26

MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)

Phase: N/A Priority: Normal
NCT ID: NCT04004559 Org: User:
Start: 05/28/19 End: 05/30/25 Due: 05/30/26

Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)

Phase: N/A Priority: Normal
NCT ID: NCT05582265 Org: User:
Start: 10/28/22 End: 10/31/30 Due: 10/31/31

Development and Prospective Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy of Neoadjuvant Treatment of Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06909643 Org: User:
Start: 01/01/22 End: 12/31/25 Due: 12/31/26

Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05329597 Org: User:
Start: 06/24/20 End: 07/31/22 Due: 07/31/23

A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT04992559 Org: User:
Start: 06/22/21 End: 05/01/27 Due: 05/01/28

A Single Arm Clinical Study of Dendritic Cell Vaccine Loaded With Circular RNA Encoding Cryptic Peptide for Patients With HER2-negative Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06530082 Org: User:
Start: 12/01/24 End: 01/01/27 Due: 01/01/28

Vaginal Profile in IVF/ICSI and Impact on Clincal Outcome

Phase: N/A Priority: Normal
NCT ID: NCT04202302 Org: User:
Start: 08/06/19 End: 03/31/20 Due: 03/31/21

Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary

Phase: N/A Priority: Normal
NCT ID: NCT06883487 Org: User:
Start: 04/07/24 End: 03/31/27 Due: 03/31/28

Efficacy and Safety of Ciprofol for the Sedation in Patients Undergoing Hysteroscopy

Phase: N/A Priority: Normal
NCT ID: NCT06172140 Org: User:
Start: 01/01/24 End: 04/30/24 Due: 04/30/25

Comparison of Clinical Effect Between Endoscopic and Microscopic Ear Surgery of Cholesteatoma: A Multicenter Retrospective Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT05182268 Org: User:
Start: 11/01/16 End: 03/30/21 Due: 03/30/22

Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04511481 Org: User:
Start: 04/15/20 End: 01/01/21 Due: 01/01/22